A longitudinal study of muscle strength and function in patients with cancer cachexia.


Journal

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
ISSN: 1433-7339
Titre abrégé: Support Care Cancer
Pays: Germany
ID NLM: 9302957

Informations de publication

Date de publication:
Jan 2019
Historique:
received: 29 09 2017
accepted: 27 05 2018
pubmed: 4 6 2018
medline: 2 2 2019
entrez: 4 6 2018
Statut: ppublish

Résumé

Patients with cancer frequently experience an involuntary loss of weight (in particular loss of muscle mass), defined as cachexia, with profound implications for independence and quality of life. The rate at which such patients' physical performance declines has not been well established. The aim of this study was to determine the change in muscle strength and function over 8 weeks in patients with already established cancer cachexia, to help inform the design and duration of physical activity interventions applicable to this patient group. Patients with thoracic and gastrointestinal cancer and with unintentional weight loss of > 5% in 6 months or BMI < 20 plus 2% weight loss were included. Physical and functional assessments (baseline, 4 weeks, 8 weeks) included isometric quadriceps and hamstring strength, handgrip, standing balance, 10-m walk time and timed up and go. Fifty patients (32 male), mean ± SD age 65 ± 10 years and BMI 24.9 ± 4.3 kg/m More than a third of patients with established cancer cachexia in our study were stable over 8 weeks, suggesting a subgroup who may benefit from targeted interventions of reasonable duration. Better understanding the physical performance parameters which characterise and differentiate these patients has important clinical implications for cancer multidisciplinary team practice.

Identifiants

pubmed: 29860710
doi: 10.1007/s00520-018-4297-8
pii: 10.1007/s00520-018-4297-8
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

131-137

Subventions

Organisme : Marie Curie
ID : MCCC-FCO-11-C
Pays : United Kingdom
Organisme : Tenovus Cancer Care
ID : 501277

Références

J Gerontol A Biol Sci Med Sci. 2006 Oct;61(10):1059-64
pubmed: 17077199
Ann Oncol. 2014 Aug;25(8):1635-42
pubmed: 24562443
PLoS One. 2013 Dec 30;8(12):e86059
pubmed: 24386491
J Neurooncol. 2009 Aug;94(1):79-85
pubmed: 19212703
Am J Clin Nutr. 2013 Oct;98(4):1012-9
pubmed: 23966429
Oncol Res Treat. 2014;37(1-2):36-41
pubmed: 24613907
J Aging Phys Act. 2015 Apr;23(2):314-22
pubmed: 24812254
BMJ. 1997 Nov 8;315(7117):1219-22
pubmed: 9393230
Support Care Cancer. 2014 Jul;22(7):1797-806
pubmed: 24531742
Psychooncology. 2018 Feb;27(2):458-464
pubmed: 28758698
Curr Opin Support Palliat Care. 2016 Dec;10(4):298-305
pubmed: 27635765
Nat Clin Pract Oncol. 2005 Mar;2(3):158-65
pubmed: 16264909
J Gerontol. 1991 Jul;46(4):M139-44
pubmed: 2071835
J Pain Symptom Manage. 2006 May;31(5):421-30
pubmed: 16716872
Lancet Oncol. 2011 May;12(5):489-95
pubmed: 21296615
Br J Cancer. 2003 Sep 15;89(6):1022-7
pubmed: 12966419
Lancet Oncol. 2008 Jul;9(7):629-35
pubmed: 18539529
Am J Respir Crit Care Med. 2013 Jul 15;188(2):193-200
pubmed: 23449691
J Am Geriatr Soc. 1991 Feb;39(2):142-8
pubmed: 1991946
Support Care Cancer. 2010 May;18(5):609-16
pubmed: 19629537
Cancer. 2008 Oct 15;113(8):2205-14
pubmed: 18780322
Nat Rev Clin Oncol. 2012 Mar 06;9(5):288-96
pubmed: 22392097
Arch Phys Med Rehabil. 1997 Jan;78(1):26-32
pubmed: 9014953
Eur Respir J. 2010 Aug;36(2):301-10
pubmed: 20110400
Oncologist. 2011;16(11):1649-57
pubmed: 21948693
J Support Oncol. 2009 Jan-Feb;7(1):27-34
pubmed: 19278175
Palliat Support Care. 2005 Dec;3(4):281-7
pubmed: 17039983
Cancer Pract. 2001 May-Jun;9(3):119-27
pubmed: 11879296
Nutr Cancer. 1999;35(2):127-9
pubmed: 10693165
Age Ageing. 1997 Jan;26(1):15-9
pubmed: 9143432
Gastroenterol Res Pract. 2011;2011:601434
pubmed: 21760776
Support Care Cancer. 2015 Jan;23(1):79-86
pubmed: 24975045

Auteurs

Nichola Gale (N)

School of Healthcare Sciences, College of Biomedical and Life Sciences, Heath Park, Cardiff University, Cardiff, CF14 4XN, UK. galens@cardiff.ac.uk.

David Wasley (D)

Cardiff School of Sport, Cardiff Metropolitan University, Cardiff, CF23 6XD, UK.

Sioned Roberts (S)

Velindre Cancer Centre, Whitchurch, Cardiff, CF14 2TL, UK.

Karianne Backx (K)

Cardiff School of Sport, Cardiff Metropolitan University, Cardiff, CF23 6XD, UK.

Annemarie Nelson (A)

Velindre Cancer Centre, Whitchurch, Cardiff, CF14 2TL, UK.

Robert van Deursen (R)

School of Healthcare Sciences, College of Biomedical and Life Sciences, Heath Park, Cardiff University, Cardiff, CF14 4XN, UK.

Anthony Byrne (A)

Marie Curie Research Centre (MCPCRC), School of Medicine, Heath Park, Cardiff University, Cardiff, CF14 4XN, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH